Home » Topics » Regulatory

Regulatory
RSS

Abbott and NaPro BioTherapeutics file ANDA for paclitaxel

March 19, 2001

New doses of Kadian approved in U.S.

March 15, 2001

Roche seeks FDA approval for Xeloda/Taxotere combination for the treatment of breast cancer

March 9, 2001

FDA approves multidose formulation of Serono's Gonal-F for ovarian stimulation

March 7, 2001

Faulding to market and sell NaPro's paclitaxel in Europe

March 5, 2001

CPMP issues positive opinion for new NeoRecormon indication

March 5, 2001

Early March launch for new antiallergic agent from Kyowa Hakko

Feb. 27, 2001

Iomed enrolls over 300 patients in phase III study for epicondylitis

Feb. 26, 2001

Janssen completes phase III trials of sustained-release formulation of Risperdal

Feb. 26, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...